Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: Risk factor or possible biases

Transfusion

Volumn 51, Issue 7, 2011, Pages 1556-1566

  Puopolo, Maria ^a   Ladogana, Anna ^a   Vetrugno, Vito ^a   Pocchiari, Maurizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE TRANSMISSION; FEMALE; HUMAN; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SPORADIC CREUTZFELDT JAKOB DISEASE;

ADULT; AGED; BIAS (EPIDEMIOLOGY); BLOOD SAFETY; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 79960173081     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03004.x     Document Type: Article

References (51)

1. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta Jde P, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, Will RG, Zerr I,. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-91. (Pubitemid 40617696)
2. Will RG, Alperovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E, de Silva R, D'Alessandro M, Delasnerie-Laupretre N, Zerr I, van Duijn C,. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann Neurol 1998; 43: 763-7. (Pubitemid 28280220)
3. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M,. Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Infect Dis 2009; 15: 265-71.
4. Ruegger J, Stoeck K, Amsler L, Blaettler T, Zwahlen M, Aguzzi A, Glatzel M, Hess K, Eckert T,. A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004. BMC Public Health 2009; 14: 9-18.
5. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL,. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353: 693-7. (Pubitemid 29103801)
6. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, Knight RS, Smith PG, Will RG,. Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol 2008; 63: 347-54. (Pubitemid 351499864)
7. van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, Zerr I, de Silva R, Wientjens DP, Brandel JP, Weber T, Bonavita V, Zeidler M, Alpérovitch A, Poser S, Granieri E, Hofman A, Will RG,. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet 1998; 351: 1081-5. (Pubitemid 28162198)
8. Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie-Lauprêtre N, Will R, Poser S,. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000; 53: 747-54. (Pubitemid 30609629)
9. Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, Cruz M, Molbak K, Laursen H, Falkenhorst G, Martínez-Martín P, Siden A, EUROSURGYCJD Research Group. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 2008; 31: 229-40.
10. Palmer MS, Dryden AJ, Hughes JT, Collinge J,. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-1.
11. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar H, van Duijn C, Will RG,. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 1673-4. (Pubitemid 29224526)
12. Weissmann C,. Thoughts on mammalian prion strains. Folia Neuropathol 2009; 47: 104-13.
13. Diringer H,. Sustained viremia in experimental hamster scrapie. Arch Virol 1984; 82: 105-9. (Pubitemid 15205722)
14. Casaccia P, Ladogana A, Xi YG, Pocchiari M,. Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie. Arch Virol 1989; 108: 145-9. (Pubitemid 20055724)
15. Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L,. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985; 2: 896-7. (Pubitemid 16242696)
16. Tateishi J,. Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet 1985; 2: 1074. (Pubitemid 16206779)
17. Tamai Y, Kojima H, Kitajima R, Taguchi F, Ohtani Y, Kawaguchi T, Miura S, Sato M, Ishihara Y,. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. N Engl J Med 1992; 327: 649.
18. Deslys JP, Lasmézas C, Dormont D,. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet 1994; 343: 848-9. (Pubitemid 24147519)
19. Brown P, Cervenáková L, Diringer H,. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001; 137: 5-13. (Pubitemid 32100170)
20. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC,. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29. (Pubitemid 24153834)
21. Coste J, Prowse C, Eglin R, Fang C,. A report on transmissible spongiform encephalopathies and transfusion safety. Vox Sang 2009; 96: 284-91.
22. Chohan G, Llewelyn C, Mackenzie J, Cousens S, Kennedy A, Will R, Hewitt P,. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Transfusion 2010; 50: 1003-6.
23. Peden A, McCardle L, Head MW, Love S, Ward HJ, Cousens SN, Keeling DM, Millar CM, Hill FG, Ironside JW,. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16: 296-304.
24. Bruce ME, McConnell I, Will RG, Ironside JW,. Detection of variant Creutzfeldt-Jakob disease infectivity in extra neural tissues. Lancet 2001; 358: 208-9. (Pubitemid 32718547)
25. Hadlow WJ, Kennedy RC, Race RE,. Natural infection of Suffolk sheep with scrapie virus. J Infect Dis 1982; 146: 657-64. (Pubitemid 13250819)
26. Jeffrey M, Ryder S, Martin S, Hawkins SA, Terry L, Berthelin-Baker C, Bellworthy SJ,. Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol 2001; 124: 280-9. (Pubitemid 32631563)
27. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ,. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356: 999-1000.
28. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F,. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83: 2897-905. (Pubitemid 35276989)
29. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, Sisõ S, González L, Jeffrey M, Hunter N,. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112: 4739-45.
30. Bons N, Lehmann S, Mestre-Francas N, Dormont D, Brown P,. Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion 2002; 42: 513-6.
31. Esmonde TF, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, Matthews WB,. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341: 205-7. (Pubitemid 23048084)
32. Hewitt PE, Llewelyn CA, MacKenzie J, Will RG,. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91: 221-30. (Pubitemid 44337279)
33. Dorsey K, Zou S, Schonberger LB, Sullivan M, Kessler D, Notari EIV, Fang CT, Dodd RY,. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009; 49: 977-84.
34. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO,. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 459-66.
35. World Health Organization. Creutzfeldt-Jakob disease (CJD) and variant CJD (vCJD), excerpt from WHO recommended standards and strategies for surveillance, prevention and control of communicable diseases. [cited 2010 Dec 13]. Available from: URL http://www.who.int/entity/zoonoses/diseases/ Creutzfeldt.pdf
36. Will RG, Matthews WB,. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982; 45: 235-8. (Pubitemid 12185335)
37. Croes EA, Roks G, Jansen GH, Nijssen PC, van Duijn CM,. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone. J Neurol Neurosurg Psychiatry 2002; 72: 792-3. (Pubitemid 34557026)
38. Brown P, Brandel JP, Preece M, Sato T,. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 67: 389-93. (Pubitemid 44214958)
39. Head MW, Ritchie D, Smith N, McLoughlin V, Nailon W, Samad S, Masson S, Bishop M, McCardle L, Ironside JW,. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164: 143-53. (Pubitemid 38364599)
40. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A, Al-Sarraj S, Ironside JW, Lantos PL, Collinge J,. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183-9. (Pubitemid 29088029)
41. World Health Organization. Tables on tissue infectivity distribution in transmissible spongiform encephalopathies, update 2010. WHO/EMP/QSM2010.1. [cited 2010 Dec 13]. Available from: URL http://www.who.int/entity/ bloodproducts/tablestissueinfectivity.pdf
42. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H,. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-33. (Pubitemid 29382879)
43. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, Dell'Omo G, Cartoni C, Ingrosso L, Boyle A, Galeno R, Sbriccoli M, Lipp HP, Bruce M, Pocchiari M, Agrimi U,. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. Plos Pathog 2006; 2: e12.
44. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P,. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-50. (Pubitemid 27435311)
45. Kitamoto T, Mohri S, Ironside JW, Miyoshi I, Tanaka T, Kitamoto N, Itohara S, Kasai N, Katsuki M, Higuchi J, Muramoto T, Shin RW,. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions. Biochem Biophys Res Commun 2002; 294: 280-6. (Pubitemid 34694090)
46. Bishop MT, Will RG, Manson JC,. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 2010; 107: 12005-10.
47. Giles K, Glidden DV, Patel S, Korth C, Groth D, Lemus A, DeArmond SJ, Prusiner SB,. Human prion strain selection in transgenic mice. Ann Neurol 2010; 68: 151-61.
48. Barash JA, Johnson BT, Gregorio DI,. Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments. Infect Control Hosp Epidemiol 2008; 29: 212-8. (Pubitemid 351269186)
49. Ladogana A, Puopolo M, Poleggi A, Almonti S, Mellina V, Equestre M, Pocchiari M,. High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology 2005; 64: 1592-7. (Pubitemid 40617697)
50. Ricketts MN,. Is Creutzfeldt-Jakob disease transmitted in blood? Is the absence of evidence of risk evidence of the absence of risk? CMAJ 1997; 157: 1367-70.
51. Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P,. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003; 43: 1687-94. (Pubitemid 37518076)